Cost savings with implementation of PNA FISH testing for identification of Candida albicans in blood cultures
- 1 April 2006
- journal article
- Published by Elsevier in Diagnostic Microbiology and Infectious Disease
- Vol. 54 (4), 277-282
- https://doi.org/10.1016/j.diagmicrobio.2005.10.011
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Guidelines for Treatment of CandidiasisClinical Infectious Diseases, 2004
- In vitro activities of voriconazole, posaconazole, and fluconazole against 4,169 clinical isolates of Candida spp. and Cryptococcus neoformans collected during 2001 and 2002 in the ARTEMIS global antifungal surveillance programDiagnostic Microbiology and Infectious Disease, 2004
- Variation in Susceptibility of Bloodstream Isolates of Candida glabrata to Fluconazole According to Patient Age and Geographic LocationJournal of Clinical Microbiology, 2003
- Comparison of Caspofungin and Amphotericin B for Invasive CandidiasisNew England Journal of Medicine, 2002
- Role of Sentinel Surveillance of Candidemia: Trends in Species Distribution and Antifungal SusceptibilityJournal of Clinical Microbiology, 2002
- Fluorescence In Situ Hybridization with Peptide Nucleic Acid Probes for Rapid Identification of Candida albicans Directly from Blood Culture BottlesJournal of Clinical Microbiology, 2002
- Epidemiology of Candidemia: 3-Year Results from the Emerging Infections and the Epidemiology of Iowa Organisms StudyJournal of Clinical Microbiology, 2002
- In Vitro Activity of the New Echinocandin Antifungal, MK-0991, against Common and Uncommon Clinical Isolates ofEuropean Journal of Clinical Microbiology & Infectious Diseases, 1999
- A Randomized Trial Comparing Fluconazole with Amphotericin B for the Treatment of Candidemia in Patients without NeutropeniaNew England Journal of Medicine, 1994
- Fluconazole-resistant Candida albicans after long-term suppressive therapyArchives of Internal Medicine, 1993